-
Mashup Score: 0Friends of Cancer Research Applauds Rep. DeGette and Rep. Bucshon for Introducing The VALID Act - Friends of Cancer Research - 1 year(s) ago
Friends of Cancer Research (Friends) applauds Larry Bucshon (R-IN) and Diana DeGette (D-CO) for their leadership introducing the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act). The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play a critical role in patient care.…
Source: Friends of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7
An individual’s best chance to fight cancer or other life-threatening disease should never be affected by something as easily preventable as a faulty diagnostic test.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
I joined cancer research advocate Jeff Allen @CancerResrch to pen this op-ed in @statnews urging Congress to include the #VALIDAct in a year-end legislative package. This bipartisan bill would set better lab test standards to support patient needs. https://t.co/cpoxkXtRb7
-
-
Mashup Score: 0AdvaMed, 45 Health Organizations Call on Congressional Leaders to Pass VALID Act - AdvaMed - 2 year(s) ago
This week, the Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers, sent a letter urging House Energy and Commerce and Senate Health, Education, Labor and Pensions leaders to enact diagnostics reform provisions (The VALID Act) in the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022.
Source: AdvamedCategories: Future of Medicine, Latest HeadlinesTweet-
NEWS: AdvaMed leads stakeholder letter calling on Congressional leaders to pass the #VALIDAct. "[Current] regulatory uncertainty … jeopardizes investment in the next generation of diagnostics that will provide for improved patient outcomes.” Read more: https://t.co/1lA6CmhTAg
-
-
Mashup Score: 2Congress must close the Theranos lab test loophole - 2 year(s) ago
Labs that create and use their own tests are not required to register them, demonstrate to independent regulators that they’re reliable, or publicly report instances of patient harm resulting from …
Source: The HillCategories: General Medicine News, Latest HeadlinesTweet-
.@theranos founder Elizabeth Holmes may have been convicted of fraud, but the policy that let the company’s faulty blood test go to market still exists. Congress should pass the bipartisan #VALIDAct recently added to the #FDASLA and close that loophole. https://t.co/lrIPE6ki8j
-
-
Mashup Score: 0May Advocacy Recap - Examining the VALID Act with Dr. Volk - 2 year(s) ago
This month we’ll be focusing on the VALID Act and its impact on laboratory developed tests. We sat down with CAP President Dr. Emily Volk to get some background on the legislation and what to expect m
Source: SoundCloudCategories: Latest Headlines, PathologyTweet-
For our May Advocacy Recap CAPcast, we sat down with CAP President @EEVMD to discuss the #VALIDact and its impact on laboratory developed tests: https://t.co/2xQUgCc6Kc. https://t.co/0iNxOeNvei
-
-
Mashup Score: 1
For most of its existence, the now-defunct biotech startup Theranos operated in so-called “stealth mode” — disclosing little about the science behind its blood-testing device while boldly claiming that it could deliver faster, more convenient, and cheaper diagnostic tests to millions of people anxious to know if they had diabetes, cancer, cardiovascular disease, or scores of other conditions.
Source: www.pewtrusts.orgCategories: General Medicine News, Latest HeadlinesTweet-
“If @US_FDA had required #Theranos to submit its lab developed tests for premarket review, the agency might have been able to shield patients from harm,” says our @RichardsonLiz The #VALIDAct would strengthen oversight to protect Americans. https://t.co/BWW6rHVUoH
-
-
Mashup Score: 2F.D.A. Warns Patients About Some Prenatal Genetic Tests - 2 year(s) ago
The agency cites concerns that some manufacturers’ claims about test performance “may not be supported with sound scientific evidence.”
Source: www.nytimes.comCategories: General Medicine News, Latest HeadlinesTweet-
“[This warning] is a helpful first step, I think what’s needed is more comprehensive reform of F.D.A.’s oversight of these tests,” says our @RichardsonLiz. The #VALIDAct would help give @US_FDA the authority it needs to protect Americans. https://t.co/HRVMncr2qY
-
-
Mashup Score: 0
The Pew Charitable Trusts wrote to the U.S. House and Senate sponsors of the Verifying Accurate Leading-edge IVCT Development (VALID) Act on Aug. 23 recommending changes intended to ensure that patients are protected under the proposed regulatory framework for in vitro clinical tests.
Source: www.pewtrusts.orgCategories: General Medicine News, Latest HeadlinesTweet-
@RepLarryBucshon @US_FDA The #VALIDAct would strengthen oversight of diagnostic tests by giving FDA clear authority to set risk-based requirements for all tests, including the ones made and used in laboratories. Recommendations👇 https://t.co/hIP3zKGtfY
-
-
Mashup Score: 0
For most of its existence, the now-defunct biotech startup Theranos operated in so-called “stealth mode” — disclosing little about the science behind its blood-testing device while boldly claiming that it could deliver faster, more convenient, and cheaper diagnostic tests to millions of people anxious to know if they had diabetes, cancer, cardiovascular disease, or scores of other conditions.
Source: www.pewtrusts.orgCategories: General Medicine News, Latest HeadlinesTweet-
“If @US_FDA had required #Theranos to submit its lab developed tests for premarket review, the agency might have been able to shield patients from harm,” says our @RichardsonLiz. The #VALIDAct would strengthen oversight to protect Americans. https://t.co/1kFKbHfnHc
-
-
Mashup Score: 0
For most of its existence, the now-defunct biotech startup Theranos operated in so-called “stealth mode” — disclosing little about the science behind its blood-testing device while boldly claiming that it could deliver faster, more convenient, and cheaper diagnostic tests to millions of people anxious to know if they had diabetes, cancer, cardiovascular disease, or scores of other conditions.
Source: www.pewtrusts.orgCategories: General Medicine News, Latest HeadlinesTweet-
The #Theranos case is just one example of how the lack of transparency and oversight in the diagnostic test industry is harmful to millions of people. If passed, the #VALIDAct could help protect vulnerable Americans, says our @RichardsonLiz https://t.co/mo3mIoEyR7
-
@CancerResrch applauds @RepDianaDeGette and @RepLarryBucshon for their leadership introducing the most recent version of the VALID Act. Read the full statement: https://t.co/UEgb4WqSQl #VALIDAct #VALID https://t.co/opyyITlFXj